Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.
Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.
Henry Schein, Inc. commemorated its 90th anniversary today by opening the Nasdaq Stock Market, reflecting on its founding in 1932 during the Great Depression. CEO Stanley M. Bergman emphasized the company's journey from a storefront pharmacy to a global leader serving over one million customers. Henry Schein has been a FORTUNE 500 member since 2004 and is part of the S&P 500 index since 2015. It employs over 22,000 Team Schein Members across 32 countries and has achieved $12.4 billion in sales for 2021, marking a 12.5% compound annual growth rate since going public.
Henry Schein (NASDAQ: HSIC) showcased a range of innovative dental and medical solutions at the AAOMS Annual Conference in New Orleans from September 12 to 17. The company highlighted products such as 3D printers, intraoral scanners, and anesthesia solutions, aiming to support oral and maxillofacial surgeons in enhancing patient care. Their team provided insights on customized solutions and showcased Henry Schein-brand products, promoting efficiency in surgical practices. The company emphasizes its commitment to being a trusted advisor to the OMS community.
Summary not available.
Henry Schein, Inc. (Nasdaq: HSIC) announced the acquisition of Midway Dental Supply, enhancing its presence in the U.S. dental distribution market. The deal includes Midway Dental’s 7,000 customers and approximately $110 million in sales, including $20 million in PPE. This acquisition allows Henry Schein to integrate Midway's sales and service teams, potentially boosting earnings over time, although it may be modestly dilutive in fiscal year 2022. CEO Steven Kizy will join Henry Schein as VP of Strategic Development.
Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of healthcare solutions for dental and medical practitioners, announced its participation in two key investor conferences in September 2022. The company will present at the Morgan Stanley 20th Annual Global Healthcare Conference in New York on September 12, followed by the Baird 2022 Global Healthcare Conference on September 14. Interested investors can access live webcasts of the presentations on the company's website, with replays available afterward. Henry Schein reported $12.4 billion in sales for 2021.
Summary not available.
Henry Schein, a leading provider of health care products, has authorized a new share repurchase program of $400 million, adding to the previously announced $400 million program in May 2021, which was fully executed. This new authorization represents approximately 3.9% of the company's outstanding shares. As of August 17, 2022, the company had around 136 million shares outstanding. The initiative reflects the company's commitment to long-term value creation and its balanced capital allocation strategy, aiming to invest in growth and shareholder value.
Henry Schein, Inc. (Nasdaq: HSIC) announced the passing of Dr. E. Dianne Rekow, a Board member since 2014 and a leader in digital dentistry. Recognized for her contributions to the field, Dr. Rekow served on the Strategic Advisory Committee and was a prominent figure in aesthetic and restorative dentistry. Her extensive academic background included roles at King's College London and NYU, along with over 100 publications and several patents. This loss may impact the company’s strategic direction given her expertise in digital solutions for dental practices.
Summary not available.
Henry Schein reported record second-quarter net sales of $3.0 billion, a 2.1% increase from the previous year. GAAP diluted EPS rose to $1.16 from $1.10 in Q2 2021. The company affirmed its full-year 2022 GAAP diluted EPS guidance of $4.75 to $4.91, indicating a growth of 7% to 10% over 2021. However, sales growth expectations were adjusted to 3% to 6% due to a strong dollar and declining demand for COVID-related products. Global Medical sales increased 10.3%, while Global Dental sales saw a 3.1% decrease.